PMID: 11061052Nov 4, 2000

Emergent angioplasty prevents left ventricular dilation in patients with acute anterior wall myocardial infarction and cardiogenic shock

Clinical Cardiology
K IwamoriK Ishikawa

Abstract

Percutaneous transluminal coronary angioplasty (PTCA) reduces in-hospital mortality and improves long-term outcome in patients with acute myocardial infarction (MI) complicated by cardiogenic shock. However, no study has evaluated the effects of different reperfusion therapies on left ventricular (LV) dimension and cardiac function in long-term survivors of MI with cardiogenic shock. We investigated the effects of PTCA on the development of LV dilation in patients who survived MI complicated by cardiogenic shock. We studied 34 patients with a first MI and cardiogenic shock in whom two-dimensional echocardiography was performed immediately after admission and 1 month after infarction. Group A consisted of 17 patients who underwent emergent PTCA during the acute phase of MI, and Group B consisted of 17 patients who did not undergo PTCA. We also studied 119 patients with a first uncomplicated acute anterior MI, including 53 who underwent PTCA (Group C) and 66 who did not (Group D). The length and wall thickness of the infarcted and noninfarcted endocardial segments were determined immediately after MI and 1 month later, and LV ejection fraction (LVEF) was measured during the chronic phase. The lengths of the infarcted and noninfar...Continue Reading

Citations

Mar 1, 1978·The American Journal of Cardiology·A L GutovitzR Roberts
Jun 1, 1978·The American Journal of Cardiology·G M Hutchins, B H Bulkley
Mar 31, 1976·The American Journal of Cardiology·B E SobelK B Larson
Dec 1, 1992·Journal of the American College of Cardiology·J R BengtsonR M Califf
Mar 11, 1992·Journal of the American College of Cardiology·M D HibbardB J Gersh
Aug 1, 1992·Journal of the American College of Cardiology·R A Kloner
Mar 1, 1991·Journal of the American College of Cardiology·L LeeW W O'Neill
Jul 14, 1988·The New England Journal of Medicine·M A PfefferE Braunwald
May 1, 1987·Journal of the American College of Cardiology·R W JeremyP J Harris
Apr 1, 1982·The American Journal of Cardiology·J A ErlebacherB H Bulkley
Oct 1, 1995·Circulation·V RichardK A Reimer
Mar 1, 1995·Journal of the American College of Cardiology·P ChareonthaitaweeJ A Rumberger
Mar 1, 1993·Journal of the American College of Cardiology·S M NidorfM H Picard

Related Concepts

Cockayne Syndrome
Tomography, Emission-Computed, Single-Photon
Gated Blood-Pool Imaging
Transluminal Route of Drug Administration
Ventricular Dysfunction, Left
Pathological Dilatation
Myocardial Infarction
Infarcted
Group B Streptococcal Pneumonia
Long-Term Survivors

Related Feeds

Cardiogenic Shock

Cardiogenic shock is a devastating consequence of acute myocardial infarction and is associated with an extremely high mortality. Here is the latest research.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.